Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113762.1.4.1235.227 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.227 |
version | 20230118 |
status | active |
publisher | B.well Connected Health Steward |
name | PneumococcalVaccine_HD_CN_Grouping |
title | Pneumococcal Vaccine_HD_CN_Grouping |
date | 2023-01-18T01:03:05-05:00 |
description | b.well created value set by Sr. Clinical Business Analyst for the Pneumococcal Vaccine - Adult Care Need. |
Usages | (none) |
This value set contains 8 concepts
Code | System | Display |
109 | http://hl7.org/fhir/sid/cvx | pneumococcal vaccine, unspecified formulation |
133 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate vaccine, 13 valent |
152 | http://hl7.org/fhir/sid/cvx | Pneumococcal Conjugate, unspecified formulation |
33 | http://hl7.org/fhir/sid/cvx | pneumococcal polysaccharide vaccine, 23 valent |
434751000124102 | http://snomed.info/sct | Pneumococcal conjugate vaccination (procedure) |
90670 | http://www.ama-assn.org/go/cpt | Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use |
90732 | http://www.ama-assn.org/go/cpt | Pneumococcal polysaccharide vaccine, 23-valent (PPSV23), adult or immunosuppressed patient dosage, when administered to individuals 2 years or older, for subcutaneous or intramuscular use |
G0009 | http://www.nlm.nih.gov/research/umls/hcpcs | Administration of pneumococcal vaccine |
Produced 08 Sep 2023